Brief: NovaBay Pharmaceuticals' Plan Of Compliance Accepted By The NYSE American
07/06/2024 12:30
June 7 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS PLAN OF COMPLIANCE ACCEPTED BY THE
NYSE
AMERICAN
Source text for Eikon: ID:nBw2TJ7fWa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing